These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
229 related articles for article (PubMed ID: 16428542)
1. The effects of dexmedetomidine on perinatal excitotoxic brain injury are mediated by the alpha2A-adrenoceptor subtype. Paris A; Mantz J; Tonner PH; Hein L; Brede M; Gressens P Anesth Analg; 2006 Feb; 102(2):456-61. PubMed ID: 16428542 [TBL] [Abstract][Full Text] [Related]
2. Effects of alpha(2)-adrenoceptor agonists on perinatal excitotoxic brain injury: comparison of clonidine and dexmedetomidine. Laudenbach V; Mantz J; Lagercrantz H; Desmonts JM; Evrard P; Gressens P Anesthesiology; 2002 Jan; 96(1):134-41. PubMed ID: 11753013 [TBL] [Abstract][Full Text] [Related]
3. Assessment of the role of alpha2-adrenoceptor subtypes in the antinociceptive, sedative and hypothermic action of dexmedetomidine in transgenic mice. Hunter JC; Fontana DJ; Hedley LR; Jasper JR; Lewis R; Link RE; Secchi R; Sutton J; Eglen RM Br J Pharmacol; 1997 Dec; 122(7):1339-44. PubMed ID: 9421280 [TBL] [Abstract][Full Text] [Related]
5. Ontogenic study of the influence of tissue plasminogen activator (t-PA) in neonatal excitotoxic brain insult and the subsequent microglia/macrophage activation. Hennebert O; Laudenbach V; Laquerriere A; Verney C; Carmeliet P; Marret S; Leroux P Neuroscience; 2005; 130(3):697-712. PubMed ID: 15590153 [TBL] [Abstract][Full Text] [Related]
6. Dexmedetomidine produces its neuroprotective effect via the alpha 2A-adrenoceptor subtype. Ma D; Hossain M; Rajakumaraswamy N; Arshad M; Sanders RD; Franks NP; Maze M Eur J Pharmacol; 2004 Oct; 502(1-2):87-97. PubMed ID: 15464093 [TBL] [Abstract][Full Text] [Related]
7. Thiorphan, a neutral endopeptidase inhibitor used for diarrhoea, is neuroprotective in newborn mice. Medja F; Lelièvre V; Fontaine RH; Lebas F; Leroux P; Ouimet T; Saria A; Rougeot C; Dournaud P; Gressens P Brain; 2006 Dec; 129(Pt 12):3209-23. PubMed ID: 17028311 [TBL] [Abstract][Full Text] [Related]
8. Dextromethorphan is protective against sensitized N-methyl-D-aspartate receptor-mediated excitotoxic brain damage in the developing mouse brain. Keller M; Griesmaier E; Auer M; Schlager G; Urbanek M; Simbruner G; Gressens P; Sárközy G Eur J Neurosci; 2008 Feb; 27(4):874-83. PubMed ID: 18279363 [TBL] [Abstract][Full Text] [Related]
9. Neuroprotection of the developing brain by systemic administration of vasoactive intestinal peptide derivatives. Gressens P; Besse L; Robberecht P; Gozes I; Fridkin M; Evrard P J Pharmacol Exp Ther; 1999 Mar; 288(3):1207-13. PubMed ID: 10027860 [TBL] [Abstract][Full Text] [Related]
10. Neuroprotective effects vary across nonsteroidal antiinflammatory drugs in a mouse model of developing excitotoxic brain injury. Leroux P; Hennebert C; Catteau J; Legros H; Hennebert O; Laudenbach V; Marret S Neuroscience; 2010 May; 167(3):716-23. PubMed ID: 20188153 [TBL] [Abstract][Full Text] [Related]
11. Systemic application of granulocyte-colony stimulating factor and stem cell factor exacerbates excitotoxic brain injury in newborn mice. Keller M; Simbruner G; Górna A; Urbanek M; Tinhofer I; Griesmaier E; Sarkozy G; Schwendimann L; Gressens P Pediatr Res; 2006 Apr; 59(4 Pt 1):549-53. PubMed ID: 16549527 [TBL] [Abstract][Full Text] [Related]
12. Neuroprotective effects of dexmedetomidine against glutamate agonist-induced neuronal cell death are related to increased astrocyte brain-derived neurotrophic factor expression. Degos V; Charpentier TL; Chhor V; Brissaud O; Lebon S; Schwendimann L; Bednareck N; Passemard S; Mantz J; Gressens P Anesthesiology; 2013 May; 118(5):1123-32. PubMed ID: 23353792 [TBL] [Abstract][Full Text] [Related]
13. The AMPA receptor positive allosteric modulator, S18986, is neuroprotective against neonatal excitotoxic and inflammatory brain damage through BDNF synthesis. Destot-Wong KD; Liang K; Gupta SK; Favrais G; Schwendimann L; Pansiot J; Baud O; Spedding M; Lelièvre V; Mani S; Gressens P Neuropharmacology; 2009 Sep; 57(3):277-86. PubMed ID: 19501111 [TBL] [Abstract][Full Text] [Related]
14. In vivo regulation of dopamine and noradrenaline release by alpha2A-adrenoceptors in the mouse nucleus accumbens. Ihalainen JA; Tanila H J Neurochem; 2004 Oct; 91(1):49-56. PubMed ID: 15379886 [TBL] [Abstract][Full Text] [Related]
15. Alpha2A-adrenoceptors are important modulators of the effects of D-amphetamine on startle reactivity and brain monoamines. Lähdesmäki J; Sallinen J; MacDonald E; Scheinin M Neuropsychopharmacology; 2004 Jul; 29(7):1282-93. PubMed ID: 15039766 [TBL] [Abstract][Full Text] [Related]
16. Vasoactive intestinal peptide prevents excitotoxic cell death in the murine developing brain. Gressens P; Marret S; Hill JM; Brenneman DE; Gozes I; Fridkin M; Evrard P J Clin Invest; 1997 Jul; 100(2):390-7. PubMed ID: 9218516 [TBL] [Abstract][Full Text] [Related]
17. Expression and function of alpha-adrenoceptors in zebrafish: drug effects, mRNA and receptor distributions. Ruuskanen JO; Peitsaro N; Kaslin JV; Panula P; Scheinin M J Neurochem; 2005 Sep; 94(6):1559-69. PubMed ID: 16000146 [TBL] [Abstract][Full Text] [Related]
18. Topiramate prevents excitotoxic damage in the newborn rodent brain. Sfaello I; Baud O; Arzimanoglou A; Gressens P Neurobiol Dis; 2005 Dec; 20(3):837-48. PubMed ID: 16009561 [TBL] [Abstract][Full Text] [Related]
19. Neuroprotective effects of NAP against excitotoxic brain damage in the newborn mice: implications for cerebral palsy. Sokolowska P; Passemard S; Mok A; Schwendimann L; Gozes I; Gressens P Neuroscience; 2011 Jan; 173():156-68. PubMed ID: 21073926 [TBL] [Abstract][Full Text] [Related]
20. In vitro and in vivo profiling of fadolmidine, a novel potent alpha(2)-adrenoceptor agonist with local mode of action. Lehtimäki J; Leino T; Koivisto A; Viitamaa T; Lehtimäki T; Haapalinna A; Kuokkanen K; Virtanen R Eur J Pharmacol; 2008 Dec; 599(1-3):65-71. PubMed ID: 18930723 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]